DrugPatentWatch Database Preview
Drugs in Development Information for Dorzagliatin
» See Plans and Pricing
What is the development status for investigational drug Dorzagliatin?
Dorzagliatin is an investigational drug.
There have been 5 clinical trials for Dorzagliatin.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2020.
The most common disease conditions in clinical trials are Diabetes Mellitus, Diabetes Mellitus, Type 2, and [disabled in preview]. The leading clinical trial sponsors are Hua Medicine Limited, Chinese University of Hong Kong, and [disabled in preview].
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for Dorzagliatin
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2020-09-01) |
| Vendors | 13 |
Recent Clinical Trials for Dorzagliatin
| Title | Sponsor | Phase |
|---|---|---|
| Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in Individuals With Recent-onset Type 2 Diabetes and Monogenic Diabetes | Chinese University of Hong Kong | Phase 2 |
| Drug Interaction Study Between Dorzagliatin and Empagliflozin | Hua Medicine Limited | Phase 1 |
| Drug Interaction Study Between Dorzagliatin and Sitagliptin | Hua Medicine Limited | Phase 1 |
Clinical Trial Summary for Dorzagliatin
Top disease conditions for Dorzagliatin
Top clinical trial sponsors for Dorzagliatin
US Patents for Dorzagliatin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dorzagliatin | Start Trial | Pyrrolidinone glucokinase activators | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| Dorzagliatin | Start Trial | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine | HUA MEDICINE (Grand Gayman, KY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dorzagliatin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dorzagliatin | Argentina | AR071474 | 2028-04-16 | Start Trial |
| Dorzagliatin | Austria | AT557017 | 2028-04-16 | Start Trial |
| Dorzagliatin | Australia | AU2009237794 | 2028-04-16 | Start Trial |
| Dorzagliatin | Brazil | BRPI0911035 | 2028-04-16 | Start Trial |
| Dorzagliatin | Canada | CA2720524 | 2028-04-16 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
